Evidence map›Paper›PMID 35631298›Full record

ArticleNutrients2022

Vitamin D Status and Gestational Diabetes in Russian Pregnant Women in the Period between 2012 and 2021: A Nested Case-Control Study.

Aleksandra S Tkachuk, Elena A Vasukova, Anna D Anopova, Tatiana L Karonova, Evgenii A Pustozerov, Yana A Teplova, Angelina I Eriskovskaya, Artem O Isakov, Elena Y Vasilieva, Maria A Kokina and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Overlap of Gestational Diabetes Mellitus and Pre-eclampsia: A Scoping Review.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026
    Review
  3. Article
  4. Reducing early pregnancy loss with vitamin DJournal of clinical biochemistry and nutrition · 2025
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Aleksandra S TkachukInstitute of Endocrinology, Almazov National Medical Research Centre, 194156 Saint Petersburg, Russia.
Elena A VasukovaInstitute of Endocrinology, Almazov National Medical Research Centre, 194156 Saint Petersburg, Russia.ORCID 0000-0002-8795-1495
Anna D AnopovaWorld-Class Research Center for Personalized Medicine, Almazov National Medical Research Centre, 194156 Saint Petersburg, Russia.ORCID 0000-0003-3107-4531
Tatiana L KaronovaInstitute of Endocrinology, Almazov National Medical Research Centre, 194156 Saint Petersburg, Russia.
Evgenii A PustozerovInstitute of Endocrinology, Almazov National Medical Research Centre, 194156 Saint Petersburg, Russia.ORCID 0000-0001-8109-1319
Yana A TeplovaInstitute of Endocrinology, Almazov National Medical Research Centre, 194156 Saint Petersburg, Russia.
Angelina I EriskovskayaWorld-Class Research Center for Personalized Medicine, Almazov National Medical Research Centre, 194156 Saint Petersburg, Russia.
Artem O IsakovWorld-Class Research Center for Personalized Medicine, Almazov National Medical Research Centre, 194156 Saint Petersburg, Russia.ORCID 0000-0002-2938-0575
Elena Y VasilievaCentral Clinical Diagnostic Laboratory, Almazov National Medical Research Centre, 194156 Saint Petersburg, Russia.
Maria A KokinaWorld-Class Research Center for Personalized Medicine, Almazov National Medical Research Centre, 194156 Saint Petersburg, Russia.
Irina Y ZazerskayaDepartment of Obstetrics and Gynecology, Almazov National Medical Research Centre, 194156 Saint Petersburg, Russia.
Tatiana M PervuninaInstitute of Perinatology and Pediatrics, Almazov National Medical Research Centre, 197341 Saint Petersburg, Russia.
Elena N GrinevaInstitute of Endocrinology, Almazov National Medical Research Centre, 194156 Saint Petersburg, Russia.
Polina V PopovaWorld-Class Research Center for Personalized Medicine, Almazov National Medical Research Centre, 194156 Saint Petersburg, Russia.ORCID 0000-0002-3697-7791
Federal Almazov North-West Medical Research Centre · RUFirst Pavlov State Medical University of St. Petersburg · RU

Funding

Ministry of Science and Higher Education of the Russian Federation Agreement No. 075-15-2022-301
6 · The paper itself

Abstract

Several meta-analyses found an association between low maternal serum 25-hydroxyvitamin D (25(OH)D) level and gestational diabetes mellitus (GDM). However, some of them reported significant heterogeneity. We examined the association of serum 25(OH)D concentration measured in the first and in the second halves of pregnancy with the development of GDM in Russian women surveyed in the periods of 2012−2014 and 2018−2021. We conducted a case−control study (including 318 pregnant women) nested on two previous studies. In 2012−2014, a total of 214 women (83 GDM and 131 controls) were enrolled before 15 weeks of gestation and maternal serum 25(OH)D concentrations were measured twice: at 8th−14th week of gestation and simultaneously with two-hour 75 g oral glucose tolerance test (OGTT) at 24th−32nd week of gestation. In the period of 2018−2021, 104 women (56 GDM and 48 controls) were included after OGTT and 25(OH)D concentrations were measured at 24th−32nd week of gestation. Median 25(OH)D levels were 20.0 [15.1−25.7] vs. 20.5 [14.5−27.5] ng/mL (p = 0.565) in GDM and control group in the first half of pregnancy and 25.3 [19.8−33.0] vs. 26.7 [20.8−36.8] ng/mL (p = 0.471) in the second half of pregnancy, respectively. The prevalence rates for vitamin D deficiency (25(OH)D levels < 20 ng/mL) were 49.4% and 45.8% (p = 0.608) in the first half of pregnancy and 26.2% vs. 22.1% (p = 0.516) in the second half of pregnancy in women who developed GDM and in women without GDM, respectively. The frequency of vitamin D supplements intake during pregnancy increased in 2018−2021 compared to 2012−2014 (p = 0.001). However, the third trimester 25(OH)D levels and prevalence of vitamin D deficiency (25.5 vs. 23.1, p = 0.744) did not differ in women examined in the periods of 2012−2014 and 2018−2021. To conclude, there was no association between gestational diabetes risk and maternal 25(OH)D measured both in the first and in the second halves of pregnancy. The increased prevalence of vitamin D supplements intake during pregnancy by 2018−2021 did not lead to higher levels of 25(OH)D.

Indexed as

Diabetes, GestationalVitamin D DeficiencyCase-Control StudiesFemaleHumansPregnancyPregnant PeopleVitamin DVitaminsVitamin DVitamins25(OH)D levelgestational diabetes mellitusvitamin D deficiencyvitamin D supplementation

Identifiers

PMID35631298
PMCPMC9143366
OpenAlexW4281264329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.